JENEX CORPORATION

Industry:

Medical Devices & Equipment

Description

The Jenex Corporation is engaged in the research, development, manufacture, marketing and licensing of medical devices and technologies. The Company focuses on its thermal therapy technology that provides relief to certain skin irritations resulting from insect bites and stings, and prevents cold sores. Therapik, the first product developed by the Company from the technology, is a Class II medical device in Canada, South Korea and the United States. Therapik relieves the pain, itch and inflammation from insect stings and bites. The Jenex Corporation has also developed a product, intercept, which prevents cold sores, and also helps to improve the condition typically associated with herpes labialis (cold sore) outbreaks. The Company's products are sold over-the-counter (OTC) without a doctor's prescription.
(Source: ARS)

News Archive

TSX Venture Exchange Daily Bulletins for December 7, 2009. Marketwire Canada; 12/7/2009 ...documents indicated within the required time period: Period Ending Symbol Company Failure to File (Y/M/D) ("JEN") The Jenex Corporation annual audited financial 09/07/31 statements annual management discussion 09/07/31 & analysis certification... ...more

IIROC: Cease Trade Order, The Jenex Corporation. Marketwire Canada; 12/4/2009 ...documents indicated within the required time period: Period Ending Symbol Company Failure to File (Y/M/D) ("JEN") The Jenex Corporation annual audited financial 09/07/31 statements annual management discussion 09/07/31 & analysis certification... ...more